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Abstract
Background: Staufen2 (Stau2), a double-stranded RNA-binding protein, is a component of neuronal RNA granules,
which are dendritic mRNA transport machines. Although Stau2 is thought to be involved in the dendritic targeting
of several mRNAs in neurons, the mechanism whereby Stau2 regulates these mRNAs is unknown. To elucidate the
functions of Stau2, we screened for novel binding partners by affinity purification of GST-tagged Stau2 from 293F
cells.
Results: Three RNA helicases, RNA helicase A, Upf1 and Mov10, were identified in Stau2-containing complexes. We
focused our studies on Upf1, a key player in nonsense-mediated mRNA decay. Stau2 was found to bind directly to
Upf1 in an RNA-independent manner in vitro. Tethering Stau2 to the 3’-untranslated region (UTR) of a reporter
gene had little effect on its expression in HeLa cells. In contrast, when the same tethering assay was performed in
293F cells, we observed an increase in reporter protein levels. This upregulation of protein expression by Stau2
turned out to be dependent on Upf1. Moreover, we found that in 293F cells, Stau2 upregulates the reporter mRNA
level in an Upf1-independent manner.
Conclusions: These results indicate that the recruitment of Stau2 alone or in combination with Upf1 differentially
affects the fate of mRNAs. Moreover, the results suggest that Stau2-mediated fate determination could be executed
in a cell type-specific manner.
Background
Gene expression is regulated in various ways throughout
the process of mRNA metabolism. In the nucleus, newly
transcribed mRNA precursors undergo maturation via
processing steps, such as 5’ end capping, splicing, 3’ end
cleavage and polyadenylation. After being exported to
the cytoplasm, the expression of mRNAs is further
modulated by the regulation of their localization, stabi-
lity and rate of translation.
In polarized cells, some mRNAs are localized at speci-
fic sites in the cytoplasm and are translated locally, thus
enabling the spatiotemporal regulation of protein
expression. In neurons, for example, several mRNAs
that harbor localization signals, which are often detected
at their 3’-untranslated regions (UTRs), are selectively
transported to dendrites, while most mRNAs remain in
the soma [1]. Neuronal RNA granules are dendritic
mRNA transport machines that contain ribosomes,
RNA-associated proteins and several translation factors,
and they are transported by KIF5 along microtubules
[2,3]. During cytoplasmic transport, mRNAs are consid-
ered to be translationally dormant because RNA gran-
ules lack tRNAs and other factors required to initiate
translation [2].
Staufen2 (Stau2), a mammalian ortholog of the Staufen
protein in Drosophila melanogaster, is a double-stranded
RNA (dsRNA)-binding protein. Stau2 is expressed
strongly in the brain and moderately in the heart [4,5]. In
neurons, Stau2 is localized in the somatodendritic com-
partment and associates with RNA granules [4,6]. The
overexpression of Stau2 in neurons increases the amount
of poly (A)+ mRNAs in dendrites [6]. The depletion of
Stau2 in mature hippocampal neurons by RNA interfer-
ence (RNAi) reduces the number of dendritic spines, sug-
gesting that Stau2 regulates the targeting, translation
and/or stabilization of the mRNAs involved in spine mor-
phogenesis [7]. Although interactions of Stau2 with the
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mRNA binding proteins Tap and the Y14-Magoh hetero-
dimer [5] have been reported, little is currently known
concerning the functions of Stau2 in mRNA regulation.
There are four splicing variants (Stau252, Stau256, Stau259
and Stau262) of Stau2 [[8] and Additional File 1 Figure
S1]. Among the Stau2 isoforms, nucleo-cytoplasmic shut-
tling proteins, Stau259 and Stau252 are exported from the
nucleus through CRM1-dependent and -independent
pathways, while Stau262 and Stau256 use only the CRM1-
independent pathway [[8,9] and our unpublished data].
Beyond that, functional differences among the isoforms
are not well known.
Upf1, an RNA helicase, was originally identified as an
essential factor for nonsense- mediated mRNA decay
(NMD) [10]. NMD is an mRNA surveillance mechanism
that degrades mRNAs containing a premature termina-
tion codon to block the production of C-terminally-
truncated proteins, which are potentially harmful to
cells [11-13]. Tethering of Upf1 to the 3’-UTR of an
mRNA, namely downstream of the termination codon,
triggers mRNA decay in HeLa cells [14].
Staufen1 (Stau1), a paralog of Stau2, has been shown
to induce the degradation of several mRNAs, such as
ADP-ribosylation factor 1 (Arf1), in HeLa and C2C12
cells [15-17]. This mRNA decay mechanism resembles
certain aspects of NMD (i.e., the essential recruitment
of Upf1 to the target mRNA through protein-protein
interactions) and is thus referred to as Stau1-mediated
mRNA decay (SMD). However, whether Stau2 also trig-
gers SMD remains unknown.
In this study, we identified Upf1 as a Stau2-interacting
protein. We found that Stau2 interacts directly with
Upf1 in an RNA-independent manner. Moreover, as
expected from a previous report [5], we found that
tethering Stau2 to the 3’-UTR of an mRNA has little
effect on its expression in HeLa cells. In contrast, we
found that tethering Stau2 to the 3’-UTR increases
mRNA and protein levels in 293F cells. Intriguingly,
Upf1 is only required for the upregulation of protein
expression. These data suggest that Stau2 differentially
regulates mRNA fate in a context-dependent manner.
Results
Identification of Upf1 as a Stau2-interacting partner
To identify proteins that interact with Stau2, we sought
cell lines in which Stau2 was endogenously expressed
and appeared to function. The expression of Stau2
mRNA in 293F and HeLa cells was confirmed by RT-
PCR (Figure 1A). Furthermore, at least two among four
splice isoforms of Stau2 [8] were detected by Western
blotting in both 293F and HeLa cell extracts, and these
became undetectable upon treatment with Stau2-target-
ing siRNAs (Figure 1B).
We established a 293F-derived cell line that stably
expresses GST-fused Stau2 (293F-GST-Stau2) and puri-
fied Stau2-containing complexes from the cell extract by
GST pull-down. The 293F cell line is a variant of the
HEK 293 cell line, which can grow in FreeStyle 293
Expression Medium (Invitrogen) as suspension culture
at high concentration (> 1 × 107/ml). We took advan-
tage of the characteristics for massive culture. Given
that the HEK 293 cell line has been suspected to be of a
neuronal cell lineage rather than a kidney epithelial cell
lineage [18] and that Stau2 has been reported to be
involved in mRNA regulation in neurons [4,6,7], interac-
tion counterparts in the 293F cell line were also attrac-
tive targets. We chose Stau259 as bait from four Stau2
isoforms. As Stau259 is exported from the nucleus by
two different pathways [9] and it has an extended C-
terminal domain (Additional File 1 Figure S1), we
expected that it might interact with a greater variety of
proteins than other isoforms. Stau2 is a component of
RNA granules, which are huge ribonucleoprotein (RNP)
complexes containing a variety of proteins and RNAs
[4,6]. Hence, it is likely that Stau2 associates with a vari-
ety of proteins, some of which indirectly interact via
RNAs, thus making it difficult to identify direct binding
partners of Stau2. To identify protein factors that
directly bind to Stau2 but not proteins that indirectly
interact via RNAs, we treated cell lysates with RNase A
before purification. GST-Stau2-containing complexes
were then isolated from the cell extract and separated
by SDS-PAGE. As shown in Figure 1C, three prominent
bands migrating between 150- and 100-kDa were
detected only in the GST-Stau2 pull-down sample.
These three bands were identified as RNA helicase A
(RHA), Upf1 and Mov10 by mass spectrometric analysis
(Figure 1C) and Western blotting (Figure 1D). These
three proteins co-immunoprecipitated with endogenous
Stau2 from HeLa cell lysates treated with RNase A (Fig-
ure 1E). Thus, three RNA helicases, RHA, Upf1 and
Mov10, were identified as Stau2-interacting partners. As
RNase A primarily digests single-stranded RNAs [19],
we cannot exclude the possibility that some structured
RNAs mediate the interaction between Stau2 and these
RNA helicases.
Stau2 interacts directly with Upf1
Upf1 has been reported to interact with Stau1 to
degrade a subset of mRNAs [15,16]. To address whether
Stau2 has the equivalent function, we examined the
interaction between Stau2 and Upf1. We purified
recombinant Stau2 and Upf1 proteins from 293F cells
and examined their interaction in vitro. As shown in
Figure 2A, the recombinant Stau2 and Upf1 proteins
interacted directly.
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Figure 1 Identification of Stau2-interacting proteins. (A) A portion (nucleotides 396-907) of the human Stau2 cDNA (GenBank ID:
NM_001164381) was amplified by RT-PCR from total RNA extracted from 293F or HeLa cells. The amplification was performed with (+) or
without (-) a reverse transcription (RT) step. The products were analyzed by agarose gel electrophoresis followed by ethidium bromide staining.
M; molecular weight marker. (B) 293F or HeLa cells were transfected with a negative control siRNA (siNC) or one of two different siRNAs to
deplete Stau2 (siStau2-1 and siStau2-2). The cells were harvested at 48 h after siRNA transfection, lysed, and subjected to Western blotting using
anti-Stau2 and anti-GAPDH antibodies. The positions of the Stau2 protein isoforms are indicated by asterisks. (C, D) GST-Stau2 and GST were
precipitated from 293F-GST-Stau2 and 293F-GST cell extracts, respectively, with glutathione-Sepharose beads. After extensive washing, the bound
proteins were eluted with reduced glutathione and subjected to SDS-PAGE. The protein bands were visualized by silver staining (C) and Western
blotting using anti-GST, anti-RHA, anti-Upf1 and anti-Mov10 antibodies (D). The three specific bands migrating between 150 and 100 kDa were
identified as RHA (142 kDa), Upf1 (124 kDa) and Mov10 (114 kDa) by mass spectrometry. M; molecular weight marker. (E) Immunoprecipitation
from HeLa cell extracts was performed using a rabbit IgG or a rabbit anti-Stau2 antibody. Two percent of the total cell lysate and 10% of the
precipitate were subjected to SDS-PAGE followed by Western blotting. HC; IgG heavy chain.
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Figure 2 Stau2 interacts directly with Upf1. (A) Recombinant FLAG-Upf1 protein was mixed with either recombinant GST-Stau2 or GST, and
the mixtures were incubated at 4 °C for 2 hr. The complexes were precipitated using glutathione-Sepharose beads. Ten percent of the total
mixture and 30% of the precipitate were subjected to SDS-PAGE followed by CBB staining. Bands of contaminated Hsp70 proteins migrate
between the 75- and 50-kDa markers. M; molecular weight marker. (B) Schematic representation of the Upf1 deletion mutants used. The
numbers denote the amino acid positions relative to the N terminus of human Upf1. The gray boxes indicate a proline/glycine (PG)-rich region,
zinc (Zn) finger domains and a serine/glutamine (SQ)-rich region. The dark gray boxes indicate conserved RNA helicase motifs. The ability to
interact with Stau2 is indicated on the right. (C) Interaction between Upf1 deletion mutants and Stau2. Each Upf1 deletion mutant fused to GST
was transiently co-expressed in 293F cells along with FLAG-Stau2. The cells were lysed at 24 h after transfection, and glutathione-Sepharose
beads were used to pull down GST-Upf1 or its deletion mutants. The precipitates were analyzed by Western blotting using anti-GST or anti-
Stau2 antibodies. Five percent of the total lysate (upper panels) and 30% of the precipitate (lower panels) were loaded. (D) Schematic
representation of the Stau2 deletion mutants used. The numbers denote the amino acid positions relative to the N terminus of rat Stau2. The
gray boxes indicate conserved dsRBDs. The ability to interact with Upf1 is indicated on the right. (E) Interaction between Upf1 and the Stau2
deletion mutants. GST-Upf1 was co-expressed in 293F cells with each GFP-fused Stau2 deletion mutant. The interaction was analyzed in the
same way as in (C). The positions of the full-length and the deletion mutant proteins are indicated by asterisks.
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Upf1 consists of a proline/glycine (PG)-rich region at
its N-terminus followed by two zinc (Zn)-finger
domains, seven RNA helicase motifs and a serine/gluta-
mine (SQ)-rich region at its C-terminus (Figure 2B)
[20]. To determine which domain is involved in the
interaction of Upf1 with Stau2, two deletion mutants of
Upf1, Upf1 (1-417) and Upf1 (417-1118), were prepared
(Figure 2B). Each GST-tagged Upf1 deletion mutant was
co-expressed with FLAG-Stau2 in 293F cells and was
pulled down from the lysates. The deletion mutant Upf1
(1-417), but not Upf1 (417-1118), co-precipitated with
Stau2 (Figure 2C), indicating that the N-terminal region
of Upf1, which contains the PG-rich region and the two
Zn-finger domains, is sufficient for interaction with
Stau2.
A similar method was used to identify the domain of
Stau2 that interacts with Upf1. Combinations or indivi-
dual dsRBDs tagged with green fluorescent protein
(GFP) were co-expressed with GST-Upf1 in 293F cells,
and their binding was tested by pull-down assays. Stau2
deletion mutants containing either dsRBD2 or dsRBD3
co-precipitated with Upf1 (Figure 2E and summarized in
Figure 2D), suggesting that Stau2 interacts with Upf1
via dsRBD2 and/or dsRBD3, although we cannot
exclude the possibility some of the small fragments were
prevented from interacting with Upf1 by steric hin-
drance caused by GFP fusion.
Tethering of Stau2 to the 3’-UTR of a reporter mRNA
enhances protein expression in 293F cells
Tethering either Upf1 [14] or Stau1 [15] to a 3’-UTR
elicits mRNA decay in HeLa cells, whereas Stau2 has
been reported to have little effect on the mRNA level
[5]. It has also been reported that Stau2 and Upf1
associate with polysomes in neurons [4] and HeLa cells
[21], respectively, suggesting that they play roles in
translational regulation. Therefore, to address whether
Stau2 and Upf1 cooperatively regulate gene expression,
we examined whether Stau2 and Upf1 affect the expres-
sion of a luciferase gene when tethered to the 3’-UTR of
its mRNA. We constructed a reporter plasmid contain-
ing a Renilla luciferase (Rluc) mRNA with eight repeats
of the MS2 phage coat protein binding sequence in its
3’-UTR (Rluc-8xMS2bs) (Figure 3A). Because both
Stau2 [5,22] and Upf1 [14,23] have been reported to
interact with exon-exon junction complex (EJC) compo-
nents, the reporter did not contain introns to minimize
the effect of EJC formation. When MS2-fused Upf1,
Stau2 or Stau1 was co-expressed in HeLa cells with the
Rluc-8xMS2bs reporter together with Firefly luciferase
(Fluc; which was used to normalize for transfection effi-
cacy), Upf1 and Stau1 reduced the Rluc activity by
approximately 50% and 30%, respectively, relative to the
control (Figure 3B, C). On the other hand, Stau2 had
little effect on reporter gene expression (Figure 3C).
Thus, using our reporter system, we obtained results
that are consistent with previously reported data in
HeLa cells [5,14,15].
We next performed the same tethering assays using
adherent culture of 293F cells. Unexpectedly, we found
that expressing either MS2-Stau2 or MS2-Stau1
enhanced the expression of the reporter gene by approxi-
mately 60% or 70%, respectively, relative to the control
(Figure 3D and Additional File 2 Figure S2). These results
indicate that tethering Stau2 to the 3’-UTR of a reporter
mRNA enhances protein expression in 293F cells, but
not in HeLa cells, suggesting that Stau2 differentially reg-
ulates gene expression in a cell type-specific manner.
Interestingly, the direct tethering of MS2-Upf1 had little
effect on reporter expression in 293F cells (Figure 3E).
This may indicate that the ability of Upf1 to trigger
mRNA decay is attenuated in 293F cells.
Stau2 tethered to the 3’-UTR of an mRNA enhances
protein expression in a Upf1-dependent manner in 293F
cells
We next investigated whether the enhancement of pro-
tein expression by Stau2 observed in 293F cells is
dependent on Upf1. We depleted Upf1 from 293F cells
by RNAi and examined the effect of Stau2 tethered to
the 3’-UTR of Rluc-8xMS2bs. Stau2 failed to enhance
the expression of the reporter gene in Upf1-depleted
293F cells (Figure 4A, D). Upf1 depletion using another
siRNA also diminished the ability of Stau2 to enhance
reporter gene expression (Figure 4B, E). Depletion of
RHA, another RNA helicase that we identified as a
Stau2-interacting partner (Figure 1B), did not affect the
ability of Stau2 to enhance reporter gene expression
(Figure 4C, F). These results indicate that Stau2
enhances protein expression by binding to the 3’-UTR
of mRNAs in a Upf1-dependent manner.
Stau2 tethered to the 3’-UTR increases mRNA levels
independently of Upf1 in 293F cells
To determine whether the enhancement of protein
expression by Stau2 is due to facilitated translation or
an increase in mRNA stability, we examined the steady-
state level of a reporter mRNA in the presence or
absence of MS2-fusion proteins. We first examined
mRNA expression using the Rluc-8xMS2bs reporter.
However, we were not able to detect clear single bands
suitable for quantitative determination (data not shown),
as is often observed in transient expression experiments.
To stabilize the expression of reporter mRNA and
enable precise quantification, we established a 293F-
derived cell line stably expressing a reporter mRNA
encoding GFP with 8xMS2bs in its 3’-UTR (293F-GFP-
8xMS2bs) (Figure 5A). This reporter system is not
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Figure 3 Tethering of Stau2 to the 3’-UTR of a reporter mRNA enhances its protein expression in 293F cells . (A) Schematic
representations of the reporter constructs. The reporter Rluc-8xMS2bs consists of a cDNA encoding the Renilla luciferase (Rluc) protein with
eight repeats of the MS2 binding site (8xMS2bs) in its 3’-UTR. The control plasmid Fluc contains a cDNA encoding the firefly luciferase (Fluc)
protein. The expression of both mRNAs is under the control of the herpes simplex virus thymidine kinase (TK) promoter. (B-E) MS2-fusion
proteins indicated below each panel were co-expressed in HeLa (B, C) or 293F cells (D, E) with Rluc-8xMS2bs and Fluc. At 48 h after transfection,
the cells were harvested and subjected to Western blotting (B, D) or luciferase assay (C, E). (B, D) Western blotting was performed using an anti-
HA antibody to detect MS2-fused proteins. (C, E) The expression of Rluc relative to that of Fluc was calculated for each transfection, and the
normalized level of the MS2 transfection was defined as 1. Values are expressed as the means ± standard error of the mean (SEM) of four
independent experiments.
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suitable for monitoring changes in protein levels because
GFP has a long half-life (~26 h) in mammalian cells
[24]. Nevertheless, we detected moderate increases in
the level of GFP in 293F-GFP-8xMS2bs cells in which
MS2-Stau2 had been expressed for 72 h by Western
blot analysis (Figure 5B) and fluorescence microscopy
(Figure 5C), supporting the results of the MS2-tethering
assay using the Rluc-8xMS2bs reporter. Next, we
Figure 4 The enhanced protein expression caused by tethering Stau2 to the 3’-UTR of an mRNA is mediated by Upf1. 293F cells were
transfected with an siRNA for Upf1 (siUpf1-1 or -2) or RHA (siRHA) or with a negative control siRNA (siNC). At 24 h after transfection, an
expression plasmid for either MS2 or MS2-Stau2 was co-transfected with plasmids for Rluc-8xMS2bs and Fluc. At 48 h after plasmid transfection,
the cells were harvested and subjected to Western blotting (A-C) or the luciferase assay (D-F). (A-C) Western blotting was performed using anti-
HA, anti-Upf1, anti-RHA and anti-GAPDH antibodies. (D-F) The expression of Rluc relative to that of Fluc was calculated for each transfection, and
the normalized level of the MS2 transfection was defined as 1. Values are expressed as the means ± SEM of four independent experiments.
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Figure 5 Tethering Stau2 to the 3’-UTR increases mRNA levels in 293F cells. (A) Schematic representation of the GFP-8xMS2bs mRNA. The
293F-GFP-8xMS2bs cell line stably expresses a reporter mRNA (driven by the TK promoter) encoding GFP with 8xMS2bs in its 3’ UTR (B) Either
MS2 or MS2-Stau2 was expressed in 293F-GFP-8xMS2bs cells. The cells were harvested at 48 h or 72 h after transfection and analyzed by
Western blotting using anti-GFP and anti-Tubulin-a antibodies. The intensity of the GFP signal was normalized to that of Tubulin-a and is
presented relative to MS2. (C) The expression of GFP in 293F-GFP-8xMS2bs cells transfected with an MS2 or MS2-Stau2 expression plasmid was
observed by fluorescence microscopy at 72 h after transfection. The GFP signal intensities were analyzed and shown by surface plot. (D) MS2-
fusion proteins were expressed in 293F-GFP-8xMS2bs cells. At 48 h after transfection, the cells were harvested and proteins and RNAs were
extracted. The proteins were analyzed by Western blotting using anti-HA and anti-GAPDH antibodies. The GFP and GAPDH mRNAs were
quantitated by Northern blotting using radiolabeled probes. (E) The GFP-8xMS2bs mRNA signal was normalized to that of GAPDH mRNA, and
the normalized level of the MS2 transfection was defined as 1. Values are expressed as the means ± SEM of three independent experiments.
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expressed MS2-fused Upf1, Stau2 or Stau1 in 293F-
GFP-8xMS2bs cells and quantitated the reporter mRNA
by Northern blot analysis (Figure 5D). Both Stau2 and
Stau1 increased the steady-state level of the reporter
mRNA by approximately three-fold relative to the con-
trol, whereas Upf1 had little effect (Figure 5E). This
result indicates that Stau2 and Stau1 stabilize mRNA by
binding to the 3’-UTR in 293F cells.
We next examined whether Upf1 is required for
Stau2-mediated mRNA stabilization. Stau2 tethered to
the 3’-UTR moderately increased the GFP protein level
in control siRNA-treated cells, but not in Upf1-depleted
cells (Figure 6A, B), supporting the results of the MS2-
tethering assay using the Rluc-8xMS2bs reporter. There-
fore, we then examined whether Upf1 is required for
Stau2-mediated mRNA stabilization using this system.
Stau2 tethered to the 3’-UTR stabilized the mRNA in
Upf1-depleted cells and in control siRNA-treated cells
(Figure 6C, D), indicating that when bound to a 3’-UTR,
Stau2 can stabilize an mRNA independently of Upf1 in
293F cells.
Discussion
In this study, we identified Upf1 as a Stau2-interacting
partner by affinity chromatography (Figure 1). Stau2 was
found to interact directly with Upf1 in an RNA-inde-
pendent manner through its dsRBD2 and dsRBD3
domains (Figure 2). It has been shown that in vitro,
dsRBD3 has strong dsRNA-binding activity, whereas
dsRBD2 does not interact with dsRNA [4]. Although the
possibility that the affinity between Stau2 and Upf1
might be regulated through the binding of dsRNA to
dsRBD3 cannot be excluded, Stau2 can interact with
Upf1 even in the absence of dsRNA. The dsRBD2 and
dsRBD3 domains are conserved among all four Stau2
isoforms (Additional File 1 Figure S1), it is less likely
that interaction with Upf1 is specific to Stau259, which
we used in this study. Given that a shorter isoform,
probably Stau252, is most abundantly expressed in 293F
cells (Figure 1E), we assume that Stau252 is also involved
in Upf1-dependent mRNA regulation in 293F cells.
Stau1, a paralog of Stau2, has been reported to interact
with Upf1 via a different domain that resides within
dsRBD4 and the tubulin-binding domain [5]. However,
our results (Figure 2B), together with a previous report
[17], indicate that Upf1 uses the same domain (which
resides in the N-terminus) to interact with both Stau1
and Stau2. Different binding modes of Stau2 and Stau1
to Upf1 might be responsible for the different results
they produced in HeLa cells (see the discussion below).
It has been shown that Stau1 mediates mRNA decay
by recruiting Upf1 to target mRNAs [15], although the
target protein levels have not been examined. We found
that tethering Stau2 to the 3’-UTR of a reporter mRNA
has little effect on its protein level in HeLa cells (Figure
3C), consistent with the results reported by Monshausen
et al. showing that Stau2 does not efficiently degrade
mRNAs when tethered to their 3’-UTR in HeLa cells
[5]. Thus, although we do not yet know why, Stau2 is
not likely to trigger mRNA decay in HeLa cells, or at
least it does so less efficiently than Stau1. The results
from our immunoprecipitation experiments indicate that
Stau2 interacts with Upf1 in HeLa cells (Figure 1E).
Therefore, a possible explanation for these different
effects is that the different domains that Stau2 and
Stau1 use to interact with Upf1 might differentially reg-
ulate its activity.
In contrast to the data obtained in HeLa cells, we
found that tethering Stau2 to the 3’-UTR of a target
mRNA increased the target’s mRNA (Figure 5E) and
protein (Figure 3E, 5B) levels in 293F cells. Stau2 was
able to stabilize mRNA, even in the Upf1-depleted con-
dition (Figure 6D). Although we do not yet know the
mechanism underlying this mRNA stabilization, Stau2
may recruit mRNA-associated proteins that protect the
mRNA from degradation. Maher-Laporte et al. isolated
Stau2-containing ribosome-free RNPs from the embryo-
nic rat brain and identified poly (A)-binding protein
cytoplasmic 1 (PABPC1) and Y box-binding protein 1
(YB1) in the particles [25]. Both PABPC1 [26,27] and
YB1 [28,29] have been reported to be able to stabilize
mRNA. Possibly, in 293F cells and in neurons, Stau2-
bound mRNAs are stabilized in RNPs containing
PABPC1 and YB1 during transport or until the time
when the translation products are required.
In contrast to mRNA stabilization mediated by Stau2,
its enhancement of protein expression is dependent on
Upf1 in 293F cells (Figure 4, 6). This suggests that
mRNAs stabilized by Stau2 are translationally dormant
and that Stau2 can upregulate protein expression at the
translational level in a Upf1-dependent manner, possibly
via the recruitment of Upf1 to target mRNAs. As far as
we know, this is the second report indicating that Upf1
functions positively in gene expression. Ajamian et al.
showed that overexpressing Upf1 enhances, whereas
depleting Upf1 reduces, HIV-1 expression at the RNA
and protein levels in HeLa cells. This enhancement
requires the ATPase activity of Upf1 but not its ability
to interact with Upf2 [30]. It would be interesting to
examine whether the ATPase activity of Upf1 is
required for the upregulation of protein synthesis by the
Stau2-Upf1 complex in 293F cells.
The results of our tethering assays indicate that Stau2,
Stau1 and Upf1 regulate mRNA differently in HeLa and
293F cells (Figure 3). SMD, which has been reported to
function in HeLa [15] and C2C12 [17] cells, is unlikely
to operate in 293F cells. Although we do not yet know
what causes this difference among cell types, this
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Figure 6 Tethering Stau2 to the 3’-UTR increases mRNA levels in a Upf1-independent manner in 293F cells. (A) 293F-GFP-8xMS2bs cells
were transfected with siUpf1 or a siNC. At 24 h after transfection, the cells were transfected with an expression plasmid for either MS2 or MS2-
Stau2. At 72 h after the plasmid transfection, the cells were harvested and analyzed by Western blotting. (B) The GFP signal was normalized to
that of Tubulina, and the normalized level of the MS2 transfection was defined as 1. Values are expressed as the means ± SEM of three
independent experiments. (C) 293F-GFP-8xMS2bs cells were transfected with siUpf1 or siNC. At 24 h after transfection, the cells were transfected
with an expression plasmid for either MS2 or MS2-Stau2. At 48 h after the plasmid transfection, the cells were harvested and analyzed by
Western blotting and Northern blotting. (D) The GFP-8xMS2bs mRNA signal was normalized to that of GAPDH mRNA, and the normalized level
of the MS2 transfection was defined as 1. Values are expressed as the means ± SEM of three independent experiments.
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difference in SMD function is attributable, at least in
part, to differences in the activity of Upf1 because Upf1
does not trigger mRNA decay in 293F cells when
directly tethered to the 3’-UTR (Figure 5E). The ATPase
activity of Upf1 is required for it to trigger mRNA decay
[31]. A recent structural study by Chakrabarti et al.
showed that binding to Upf2 induces a conformational
change in Upf1 that turns on its ATPase activity [32].
The phosphorylation of Upf1 is also required for NMD
[33,34], although its effects on Upf1’s ATPase activity
are still unknown. In addition, the efficiency of NMD
has been reported to vary among different yeast strains
[35], mammalian tissues [36,37] and even among differ-
ent single cell-derived cell lines [38]. To test the possibi-
lity that the activity of Upf1 is differentially regulated in
different cell lines, it would be tempting to look for dif-
ferences in the association between Upf2 and Upf1 and
in the phosphorylation of Upf1 in HeLa versus 293F
cells.
In addition to Upf1, we identified two RNA helicases,
RHA and Mov10, as Stau2-interacting partners (Figure
1), both of which are reportedly involved in translational
regulation [39-41]. Interestingly, RHA was identified as
a component of Stau1-containing RNPs in 293T cells
[42], suggesting that RHA is a common interacting part-
ner of Stau1 and Stau2. Given that RHA facilitates the
translation of several mRNAs such as JUND mRNA
thorough the structured post-transcriptional control ele-
ment at their 5’-UTR [39], it would be interesting to
examine the effects of tethering of Stau1 or Stau2 to a
structured 5’-UTR on the mRNA translation.
Conclusions
In this study, we examined the roles of Stau2 in mRNA
regulation using artificial reporter systems. Our findings
indicate that Stau2, when bound to a 3’-UTR, enhances
mRNA translation and stabilizes the mRNA through
Upf1-dependent and -independent mechanisms respec-
tively in a cell-type specific manner. As far as we know,
mRNAs that bind directly to Stau2 have not yet been
identified. To understand mRNA regulation by Stau2 in
more detail and to elucidate its physiological roles,
mRNAs that are recognized specifically by Stau2 should
be identified in future studies.
Methods
Cloning and plasmid construction
A mammalian expression vector, pCAGwTag, was con-
structed as follows: a neomycin resistance gene expression
cassette isolated from the loxP-PGK-neoW vector [43]
was inserted into a pBluescript SK(-) vector (Stratagene)
that had been treated with SspI. The resulting plasmid was
denoted as pBSPGKNeo. The pCAGGS vector [44] was
digested with SalI and EcoRI to isolate a DNA fragment
encoding the CAG promoter. A cDNA encoding glu-
tathione S-transferase was amplified by PCR using
pGEX6P3 (GE Healthcare) as a template. Both DNA frag-
ments were inserted into the XhoI-BamHI site of
pBSPGKNeo, and the resulting plasmid was designated as
pBSpCAGGST. Double-stranded oligonucleotides encod-
ing a 3xFLAG peptide tag sequence (DYKDHDGDYKDH-
DIDYKDDDDK) along with a DNA fragment encoding
the rabbit b-globin polyadenylation signal, which had been
isolated from pCAGGS by EcoRI and HindIII (blunt end)
digestion, were inserted into pBSpCAGGST that had been
linearized by treatment with MfeI and SacI (blunt end).
The resulting vector, designated pCAGwTag, encodes glu-
tathione S-transferase (GST) and 3xFLAG tags and con-
tains the PreScission protease recognition sequence
(LEVLFQGP) between the tags.
To construct the pCMV-MS2 vector, a cDNA encod-
ing the MS2 phage coat protein in the pBC12/MS2 vec-
tor [45] was amplified by PCR using the following
primers: forward, 5’-GATACCGGTCGCCACCAT-
GAGCGCTTCTAACTTTACTCAG-3’ and reverse, 5’-
CATTGTACACTGCATAGTCCGGGACGTCATAGG-
GATAGCC-3’. The PCR product was digested with
AgeI and BsrGI and cloned into the AgeI-BsrGI site of
the pEGFP-C1 vector.
To construct the pRL-TK (-intron) vector, the pRL-
TK vector (Promega) was digested with HindIII and
NheI, blunted and self-ligated.
A cDNA encoding firefly luciferase was isolated from
pGL3-basic (Promega) by digestion with NheI and
BamHI. The cDNA fragment was ligated into the
BamHI-NheI site of the pRL-TK vector. The resulting
plasmid was designated pFL-TK.
To construct the pFL-TK (-intron) vector, pFL-TK
was digested with HindIII, treated with Klenow frag-
ment and then self-ligated. The pFL-TK (-intron) vector
was used as a Fluc mRNA expression plasmid.
Rat Stau2 (GenBank ID: AY684789) was cloned as
previously described [9]. To produce expression plas-
mids for GST-Stau2, FLAG-Stau2, GFP-Stau2 and MS2-
Stau2, the cDNA encoding Stau2 was cloned into
pCAGwTag, pCMV-FLAG, pEGFP-C1 (Clontech) and
pCMV-MS2, respectively. The construction of GFP-
Stau2 (1-210), GFP-Stau2 (1-105), GFP-Stau2 (96-210),
GFP-Stau2 (175-240), GFP-Stau2 (211-539), GFP-Stau2
(276-342) and GFP-Stau2 (287-539) has been described
previously [9]. A GFP-Stau2 (96-241) expression plasmid
was constructed by inserting the BsrGI-AflII fragment of
rat Stau2 cDNA, in which the AflII site had been
blunted, into the BsrGI-SmaI site of the pEGFP-C2 vec-
tor. A GFP-Stau2 (96-178) expression plasmid was con-
structed by insertion of the NheI-HindIII fragment of
GFP-Stau2 (96-210) into the NheI-HindIII site of the
pEGFP-C2 vector.
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A cDNA encoding human Upf1 (GenBank ID:
NM_002911) was amplified from an EST clone (Open
Biosystems Catalog No. MHS1010-9204820) that encodes
the full length Upf1 cDNA by PCR using the following pri-
mers: forward, 5’-CTTAGATCTATGAGCGTGGAGG-
CGTACG-3’ and reverse, 5’-GTAAGCTTCTCAAATC-
TCCCAGGTCC-3’. The PCR product was digested with
BglII and HindIII and cloned into the pmRFP-C1 vector.
To construct GST-Upf1 and MS2-Upf1 expression plas-
mids, the cDNA of Upf1 was cloned into pCAGwTag and
pCMV-MS2, respectively. A GST-Upf1 (1-417) expression
plasmid was constructed from GST-Upf1 by deleting the
SalI fragment. A GST-Upf1 (417-1118) expression plasmid
was constructed by inserting a SalI-EcoRI fragment iso-
lated from GST-Upf1, in which the SalI site had been
blunted, into the HindIII-EcoRI site of the pmRFP-C1 vec-
tor, in which the HindIII site had been blunted.
A cDNA encoding rat Stau1 (GenBank ID:
NM_053436) was cloned from a rat brain cDNA library
(Clontech) by PCR using the following primers: forward,
5’-GTCGAATTCATGTATAAGCCCGTGGACCCC-
CACTCTCGG-3’ and reverse, 5’-GCTGGATCCCAC-
CATGTCTTGGCCCACTGGAGTTATCAG-3’. The
PCR product was digested with EcoRI and BamHI and
cloned into pEGFP-C1. To construct an MS2-Stau1
expression vector, the Stau1 cDNA was cloned into the
pCMV-MS2 vector.
To construct a renilla luciferase mRNA expression
plasmid harboring the 8xMS2 binding site (8xMS2bs) at
the 3’-UTR (pRL-TK (-intron)-8xMS2bs), a DNA frag-
ment encoding 8xMS2bs was isolated from the RSV-b-
gal-MS2bs-CaMKIIa3’UTR vector [46] by BamHI and
BglII digestion, followed by T4 DNA polymerase treat-
ment and ligated into a pRL-TK (-intron) vector that
had been digested with XbaI and blunted.
A plasmid expressing a GFP mRNA harboring 8xMS2bs
at its 3’-UTR (pTK-GFP-8xMS2bs) was constructed as fol-
lows: synthetic oligonucleotides encoding the FLAG epi-
tope tag (top, AGCTACGCCACCATGGACTACAAG-
GACGACGATGACA and bottom, AGCTTGTCAT-
CGTCGTCCTTGTAGTCCATGGTGGCGT) were
annealed and ligated into the HindIII site of the pRL-TK
vector (pRL-TK-FLAG). A DNA fragment that includes
the TK promoter and the FLAG epitope was isolated from
pRL-TK-FLAG by BglII and NheI digestion and ligated
into the pEGFP-N1 vector from which the CMV promoter
was deleted by AseI and NheI digestion (pTK-GFP). The
8xMS2bs fragment was isolated from the pRL-TK
(-intron)-8XMS2bs vector by BamHI and NotI digestion
followed by T4 DNA polymerase treatment and ligated
into a pTK-GFP vector that had been treated with BsrGI-
NotI and T4 DNA polymerase. Finally, the chimeric intron
of the resulting plasmid was removed by digestion with
BspMI and NheI.
Antibodies
A rabbit polyclonal anti-rat Stau2 (rStau2) antibody was
raised against the peptide sequence HLREKADNN-
QANPGSITQDC of rat Stau2. Immunization and affi-
nity purification of the antibody were done at MBL Co.,
Ltd. A rabbit anti-human Stau2 (hStau2) antibody
(RN013P, MBL), a rabbit anti-GST antibody (Z-5, Santa
Cruz Biotechnology), a goat anti-Upf1 antibody
(BL409G, Bethyl Laboratories), a rabbit anti-Mov10 anti-
body (A301-571A, Bethyl Laboratories), a mouse anti-
HA antibody (HA-7, Sigma-Aldrich), a mouse anti-
GAPDH antibody (6C5, Ambion), a rabbit anti-GFP
antibody (A6455, Molecular Probes) and a mouse anti-
Tubulin-a antibody (DM1A, Sigma-Aldrich) were pur-
chased. Kotani et al. [47] generated the rat anti-RHA
antibody (8E3).
Cell culture
HeLa and 293F (Invitrogen) cells were cultured in Dul-
becco’s modified Eagle’s medium (Sigma-Aldrich) sup-
plemented with 10% fetal calf serum at 37 °C in a 5%
CO2 atmosphere.
Preparation of stable cell lines
The plasmids encoding GST-Stau2, GST or GFP-
8xMS2bs were linearized by restriction enzyme digestion
and transfected into 293F cells using Effectene (Qiagen).
At 24 h after transfection, G418 (Gibco) was added at a
final concentration of 0.8 mg/ml. After 3 days of incuba-
tion, the cells were re-plated, and individual clones were
selected for their expression of GST-Stau2, GST, and
GFP. These cell lines were designated 293F-GST-Stau2,
293F-GST, and 293F-GFP-8xMS2bs, respectively.
RT-PCR
Total RNA was extracted from the 293F or HeLa cells
using TRIzol reagent (Invitrogen) according to the man-
ufacturer’s protocol. To detect the expression of Stau2,
the nucleic acid sequence 396-931 of human Stau2
cDNA (GenBank ID: NM_001164381) was amplified
from 1 μg of total RNA by RT-PCR using the Super-
Script III One-Step RT-PCR System (Invitrogen) accord-
ing to the manufacturer’s protocol. The following
primers were used: forward, 5’-ACAAGCTGCTAGA-
CACAATGCTGC-3’, and reverse, 5’- GCATCA-
CAAATTCTCGACGTCGAGG-3’. The PCR products
were analyzed by agarose gel electrophoresis followed by
ethidium bromide staining.
RNA interference
Stealth siRNAs for the negative control (NC) and the
depletion of Stau2 or RHA were obtained from Invitro-
gen: siNC, 5’-AGCUACACUAUCGAGCAAUUAACUU-
3’; siStau2-1, 5’-
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depletion of Upf1, the following siRNAs were obtained
from NipponEGT: siUpf1-1, 5’-GAUGCAGUUCCG-
CUCCAUU-d(TT)-3’ [15]; siUpf1-2, 5’-CCAAGG-
CAUUGGCUUUUUAd(TT)-3’. The siRNAs were
transfected into 293F or HeLa cells at a concentration
of 1.6 nM using Lipofectamine RNAiMax reagent (Invi-
trogen) according to the manufacturer’s protocol for
reverse transfection. For experiments using exogenous
protein expression, the culture medium was exchanged
and the cells were transfected with expression plasmids
for MS2 or MS2-Stau2 using Effectene at 24 h after
siRNA transfection. At 48 h after plasmid transfection,
the cells were harvested for luciferase assays, Northern
blotting or Western blotting.
Affinity chromatography
293F-GST-Stau2 or 293F-GST cells were cultured in
suspension in 100 ml of FreeStyle 293 Expression Med-
ium (Invitrogen) at 37 °C in a 5% CO2 atmosphere on
an orbital shaker platform rotating at 125 rpm until the
cell density reached 3 × 106/ml. The cells were har-
vested, washed with PBS and then lysed in lysis buffer
(20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT,
0.5% Tween 20, 20 μg/ml RNase A) for 15 min on ice.
The cell lysates were centrifuged at 10,000 × g for 20
min to remove insoluble material. The supernatant was
incubated with glutathione-Sepharose 4B beads (GE
Healthcare) for 2 h at 4 °C with gentle agitation. The
beads with bound proteins were isolated by centrifuga-
tion at 3,000 × g for 2 min. The beads were then
washed five times with lysis buffer without RNase A.
GST-Stau2 or GST proteins were eluted in 200 μl of
elution buffer (100 mM Tris-HCl (pH 8.3), 100 mM
NaCl, 2 mM DTT, 1 mM EDTA, 20 mM reduced glu-
tathione) on ice for 15 min. The eluted proteins were
separated by SDS-PAGE followed by silver staining.
Each band was analyzed by mass spectrometry.
Immunoprecipitation
HeLa cells (1 × 107) were lysed in 1 ml of lysis buffer
(20 mM Tris-HCl (pH7.5), 150 mM NaCl, 1 mM DTT,
0.5% Tween 20, 20 μg/ml RNase A) for 15 min on ice.
The cell lysates were centrifuged at 10,000 × g for 20
min to remove insoluble material. The supernatant was
incubated with rabbit IgG (10 μg) or a rabbit anti-
hStau2 (10 μg) antibody for 1 h on ice followed by the
addition of Protein G Sepharose 4 Fast Flow (GE
Healthcare) and incubation at 4 °C with gentle agitation
for 2 h. The beads with the bound proteins were iso-
lated by centrifugation at 3,000 × g for 2 min. The
beads were washed three times with 1 ml of lysis buffer
without RNase A. The bound proteins were eluted in
100 μl of SDS sample buffer (63 mM Tris-HCl (pH 6.8),
5 mM DTT, 2% SDS, 5% sucrose, 0.01% Bromophenol
Blue). Two percent of the total lysate and 10% of the
precipitate were separated by SDS-PAGE followed by
Western blotting.
Recombinant protein production
Recombinant GST-Stau2 and GST proteins were puri-
fied from 293F-GST-Stau2 and 293F-GST cells, respec-
tively. The cells were cultured in suspension in FreeStyle
293F Expression Medium at 37 °C in a 5% CO2 atmo-
sphere on an orbital shaker platform rotating at 125
rpm. The cells were harvested, washed with PBS, and
then lysed in lysis buffer (20 mM Tris-HCl (pH 7.5),
800 mM NaCl, 1 mM DTT, 0.5% Tween20, 20 μg/ml
RNase A) for 15 min on ice. The cell lysates were cen-
trifuged at 12,500 × g for 20 min to remove insoluble
material. The supernatant was incubated with glu-
tathione-Sepharose 4B beads for 2 h at 4 °C with gentle
agitation. The beads with bound proteins were isolated
by centrifugation at 3,000 × g for 2 min. The beads
were washed six times with lysis buffer without RNase
A. GST-Stau2 or GST protein was eluted in elution buf-
fer (100 mM Tris-HCl (pH 8.3), 100 mM NaCl, 2 mM
DTT, 1 mM EDTA, 20 mM reduced glutathione) on ice
for 15 min. The solvent was then replaced by stock buf-
fer (20 mM Tris-HCl (pH7.5), 150 mM NaCl, 1 mM
DTT) using PD-10 Desalting Columns (GE Healthcare).
Recombinant FLAG-Upf1 protein was produced using
the FreeStyle 293F Expression System (Invitrogen)
according to the manufacturer’s protocol. Briefly, GST-
FLAG-Upf1 was transiently transfected into 293F cells.
The cells were lysed, and GST-FLAG-Upf1 was purified
using glutathione-Sepharose 4B beads as described
above. The FLAG-Upf1 protein was eluted in stock buf-
fer by PreScission protease digestion (GE Healthcare).
In vitro binding assay
Recombinant FLAG-Upf1 protein (5 μg) was mixed with
recombinant GST-Stau2 protein (1 μg) or GST protein
(1 μg) in 800 μl of binding buffer (20 mM Tris-HCl (pH
7.5), 150 mM NaCl, 1 mM DTT, 0.05% Tween 20) at 4
°C for 2 hr with gentle agitation and then precipitated
using glutathione-Sepharose 4B beads. The beads were
washed five times with binding buffer. The bound pro-
teins were eluted in 50 μl of sample buffer (60 mM
Tris-HCl (pH 6.8), 1.7% SDS, 6% glycerol, 100 mM
DTT, 0.002% bromophenol blue). Ten percent of the
total cell extract and 30% of the precipitate were ana-
lyzed by SDS-PAGE followed by Coomassie brilliant
blue (CBB) staining.
Miki et al. BMC Molecular Biology 2011, 12:48
http://www.biomedcentral.com/1471-2199/12/48
Page 13 of 15
In vivo binding assay
293F cells were cotransfected with the Stau2 and Upf1
expression vectors using Effectene (Qiagen) according to
the manufacturer’s protocol. At 24 h after transfection,
the cells were harvested and lysed in 800 μl of lysis buf-
fer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM
DTT, 0.5% Tween20, 20 μg/ml RNase A). The lysate
was centrifuged at 12,500 × g for 20 min to remove
insoluble material. The supernatant fraction was incu-
bated with glutathione Sepharose beads for 2 h at 4 °C
with gentle agitation. The beads were then washed five
times with lysis buffer without RNase A. The bound
proteins were eluted in 50 μl of sample buffer. Five per-
cent of the total cell lysate and 30% of the precipitate
were analyzed by SDS-PAGE and Western blotting.
MS2 tethering assay
293F or HeLa cells cultured in 35-mm dishes were co-
transfected with plasmids encoding Rluc-8xMS2bs (0.1
μg) and Fluc (0.1 μg) mRNAs along with a plasmid encod-
ing an MS2-fused protein (0.2 μg) with or without a plas-
mid encoding a GST-fusion protein (0.4 μg). At 48 h after
transfection, the cells were harvested and assayed for luci-
ferase activity using the Dual-Luciferase Reporter Assay
System (Promega) according to the manufacturer’s proto-
col. The Rluc activity in each transfection was normalized
to the co-expressed Fluc activity. At least three indepen-
dent transfections were performed in each experiment.
293F-GFP-8xMS2bs cells were cultured in 60-mm
dishes and transfected with a plasmid encoding an MS2-
fusion protein (1.0 μg). At 48 h after transfection, total
RNA was extracted from the cells using TRIzol reagent.
Two micrograms of total RNA was separated on a 1.3%
agarose-formaldehyde gel and transferred to a Hybond-
N+ membrane (GE Healthcare). A template cDNA for
GFP was isolated from the pEGFP-C1 vector by NheI-
BsrGI digestion. A template cDNA for GAPDH was
amplified by PCR using the following primers: forward,
5’-CAAGGTCATCCCTGAGCTGAAC-3’ and reverse,
5’-GGGTCTACATGGCAACTGTGAG-3’. 32P-labeled
probes were prepared using a random prime DNA label-
ing kit (Takara Biomedicals). Hybridization was carried
out in Hybridization Solution (Nacalai tesque) according
to the manufacturer’s protocol. The membranes were
exposed to an imaging plate (Fuji Film), and the signals
were visualized using a Bio-Imaging analyzer (BAS-2500,
Fuji Film). The intensity of the signals below saturation
was measured by Scion Image (Scion Corporation). The
signal intensity of GFP-8xMS2bs mRNA in each trans-
fection was normalized to that of GAPDH mRNA.
Fluorescence microscopy
At 72 h after transfection, 293F-GFP-8xMS2bs cells
transiently expressing MS2 or MS2-Stau2 were observed
using a Zeiss Axiovert 200 fluorescent microscope (Carl
Zeiss). GFP signal intensities were analyzed by ImageJ
software surface plot program.
Additional material
Additional file 1: Schematic representation of Stau2 isoforms. Stau2
has four splice variants, and they differ in N- and C-terminal sequences
each other.
Additional file 2: Specificity validation of the MS2 tethering assay
system. To confirm that MS2-fusion proteins are specifically tethered to
the MS2 binding sites at 3’-UTR of the reporter mRNA, we show that
GST-Stau2 does not affect the activity of the reporter with MS2 binding
sites and that MS2-Stau2 does not affect the activity of the reporter
without MS2 binding sites.
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